Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.
Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.
Severity assessment of acute pulmonary embolism with spiral CT: evaluation of two modified angiographic scores and comparison with clinical data.
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
See All 24 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
Krieg AM. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Curr Oncol Rep. 2004 Mar; 6(2):88-95.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Animals
Antineoplastic Agents
Cancer Vaccines
CpG Islands
Humans
Immunotherapy
Membrane Glycoproteins
Mice
Models, Animal
Neoplasms
Oligodeoxyribonucleotides
Receptors, Cell Surface
Toll-Like Receptor 9
Toll-Like Receptors
authors with profiles
Arthur M Krieg MD